Is it clear how to access all supporting data? Not Applicable

Do you have any ethical concerns with this paper? No
Have you any concerns about statistical analyses in this paper? No
Recommendation?
Accept with minor revision (please list in comments)
Comments to the Author(s)
The article is very interesting, and demonstrates the mechanisms involving the toxic effects of Ageratina adenofora in the spleen of treated mice. Some considerations should be examined. In the abstract the authors stated that the data indicate that A. adenofora impairs spleen function, however there is no evidences for this, despite the oxidative stress and pyroptosis. Maybe change the word indicate by suggest. Please confirm the age of mice -48 weeks?
Decision letter (RSOS-190127.R0) 
21-May-2019
Dear Dr Hu,
The editors assigned to your paper ("Ageratina adenophora causes spleen toxicity by inducing oxidative stress and pyroptosis in mice") have now received comments from reviewers. We would like you to revise your paper in accordance with the referee and Associate Editor suggestions which can be found below (not including confidential reports to the Editor). Please note this decision does not guarantee eventual acceptance.
Please submit a copy of your revised paper before 13-Jun-2019. Please note that the revision deadline will expire at 00.00am on this date. If we do not hear from you within this time then it will be assumed that the paper has been withdrawn. In exceptional circumstances, extensions may be possible if agreed with the Editorial Office in advance. We do not allow multiple rounds of revision so we urge you to make every effort to fully address all of the comments at this stage. If deemed necessary by the Editors, your manuscript will be sent back to one or more of the original reviewers for assessment. If the original reviewers are not available, we may invite new reviewers.
To revise your manuscript, log into http://mc.manuscriptcentral.com/rsos and enter your Author Centre, where you will find your manuscript title listed under "Manuscripts with Decisions." Under "Actions," click on "Create a Revision." Your manuscript number has been appended to denote a revision. Revise your manuscript and upload a new version through your Author Centre.
When submitting your revised manuscript, you must respond to the comments made by the referees and upload a file "Response to Referees" in "Section 6 -File Upload". Please use this to document how you have responded to the comments, and the adjustments you have made. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response.
In addition to addressing all of the reviewers' and editor's comments please also ensure that your revised manuscript contains the following sections as appropriate before the reference list:
• Ethics statement (if applicable) If your study uses humans or animals please include details of the ethical approval received, including the name of the committee that granted approval. For human studies please also detail whether informed consent was obtained. For field studies on animals please include details of all permissions, licences and/or approvals granted to carry out the fieldwork.
• Data accessibility It is a condition of publication that all supporting data are made available either as supplementary information or preferably in a suitable permanent repository. The data accessibility section should state where the article's supporting data can be accessed. This section should also include details, where possible of where to access other relevant research materials such as statistical tools, protocols, software etc can be accessed. If the data have been deposited in an external repository this section should list the database, accession number and link to the DOI for all data from the article that have been made publicly available. Data sets that have been deposited in an external repository and have a DOI should also be appropriately cited in the manuscript and included in the reference list.
If you wish to submit your supporting data or code to Dryad (http://datadryad.org/), or modify your current submission to dryad, please use the following link: http://datadryad.org/submit?journalID=RSOS&manu=RSOS-190127
• Competing interests Please declare any financial or non-financial competing interests, or state that you have no competing interests.
• Authors' contributions All submissions, other than those with a single author, must include an Authors' Contributions section which individually lists the specific contribution of each author. The list of Authors should meet all of the following criteria; 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published.
All contributors who do not meet all of these criteria should be included in the acknowledgements.
We suggest the following format: AB carried out the molecular lab work, participated in data analysis, carried out sequence alignments, participated in the design of the study and drafted the manuscript; CD carried out the statistical analyses; EF collected field data; GH conceived of the study, designed the study, coordinated the study and helped draft the manuscript. All authors gave final approval for publication.
• Acknowledgements Please acknowledge anyone who contributed to the study but did not meet the authorship criteria.
• Your manuscript has been reviewed by 3 reviewers. While all reviewers agree that the work is interesting, several points of concerns were brought up. In particular there is a lack of description/details in some parts and the placement into context of broader field could be done more thoroughly. I recommend a major revision with a point-by-point response to each concern before considering the manuscript any further.
Comments to Author:
Reviewers' Comments to Author: Reviewer: 1 Comments to the Author(s) The manuscript by Sun et al., describes an experiment where 40 mice divided into groups of ten and then fed either control, 10%, 20%, or 30% A. adenophora in the form of a pelleted diet for 42 days. At the end of the study, the mice were sacrificed, spleens removed, and assays were performed. Comments: Introduction General comment: What motivated the investigators to test pyroptosis? More detail would be helpful to understand why the work was performed. Perhaps this could be used to better organize the introduction. Lines 64-65, Due to the lack of detail I cannot assess the validity of the statement "that it is unclear whether the toxic effects of A. adenophora on splenocyte involve pyroptosis."
Materials and methods General comment, for the sake of the reader who isn't an immunologist please try to limit your use of abbreviations or at least define them. 
Results
The authors should consider combining the results and discussion section to guide the reader through the data. This would allow for greater detail. For example, how exactly is NRRP3 an immune system damage sensor? The authors mention dose-dependency, a chemical characterization of the plant material and specific concentrations of plant compounds would provide greater support to this statement. Discussion The authors set out to investigate if A. adenophora causes oxidative stress and pyroptosis. A figure illustrating the pyroptocic pathway and a point by point discussion of this pathway with regard to the experimental results would improve the discussion.
Reviewer: 2
Comments to the Author(s) The authors present an interesting study of the spleen toxicity caused by Ageratina adenophora. This work provided a new insight into the mechanism of the toxicity of A. adenophora in a mice model. I agree to publish by Royal Society Open Science. But I have some comments: 1. Line 20: "Glutathione peroxidase" should be abbreviated to GPx. And abbreviations should be unified in line 94, 162 and 218. 2. The manuscript has some grammatical issues, and the authors should correct and improve them. The tenses of sentences should be consistent. Such as in lines 17-20, "the decrease…" should be corrected as "decreased the …" 3. Lines 113: space should be between number and unit. Same errors should corrected in Figure 6 . 4. Line 75: The source format of reagent is generally expressed as "city, province and country", however, the sentence of line 75 lacks "province". 5. Line 123: replace "μl" with "μL". 6. What are "20% and 30% groups"? 7. Line 212: Please correct the expression of this sentence. 8. Although the manuscript is generally written clearly. Pay attention to minor errors. For Figure  5 caption, some words misspelled, which is confusing to read. 9. In figure 3A , high resolution picture should be used so that the reader could see the data clearly. 10. There are some unscientific expression. For instance, the "p" in line 199, 201 and 201 should be expressed in italics. The whole Ms should be revised. 11. Please modify the format of references according to magazine's requirements.
Reviewer: 3
Comments to the Author(s) The article is very interesting, and demonstrates the mechanisms involving the toxic effects of Ageratina adenofora in the spleen of treated mice. Some considerations should be examined. In the abstract the authors stated that the data indicate that A. adenofora impairs spleen function, however there is no evidences for this, despite the oxidative stress and pyroptosis. Maybe change the word indicate by suggest. Please confirm the age of mice -48 weeks? 
Recommendation? Accept as is
Comments to the Author(s) Acceptable
Review form: Reviewer 2
Is the manuscript scientifically sound in its present form? Yes
Are the interpretations and conclusions justified by the results? Yes
Is the language acceptable? Yes
Do you have any ethical concerns with this paper? No
Recommendation? Accept as is
Comments to the Author(s) I am no another comments to this manuscript!
Decision letter (RSOS-190127.R1)
25-Jun-2019
Dear Dr Hu, I am pleased to inform you that your manuscript entitled "Ageratina adenophora causes spleen toxicity by inducing oxidative stress and pyroptosis in mice" is now accepted for publication in Royal Society Open Science.
You can expect to receive a proof of your article in the near future. Please contact the editorial office (openscience_proofs@royalsociety.org and openscience@royalsociety.org) to let us know if you are likely to be away from e-mail contact. Due to rapid publication and an extremely tight schedule, if comments are not received, your paper may experience a delay in publication.
Royal Society Open Science operates under a continuous publication model (http://bit.ly/cpFAQ). Your article will be published straight into the next open issue and this will be the final version of the paper. As such, it can be cited immediately by other researchers. As the issue version of your paper will be the only version to be published I would advise you to check your proofs thoroughly as changes cannot be made once the paper is published.
On behalf of the Editors of Royal Society Open Science, we look forward to your continued contributions to the Journal. Consistent with this, our previous study has approved that ≥ 20% dose of A. adenophora increased the liver weight and caused extensive inflammation, in addition to decreasing antioxidant activity, increasing the production of reactive oxygen species (ROS) ."
Lines 64-65, Due to the lack of detail I cannot assess the validity of the statement "that it is unclear whether the toxic effects of A. adenophora on splenocyte involve pyroptosis."
Response:
We have revised this statement in lines 62-66 to clarify the purpose to investigate pyroptosis, which may be a new mechanism involved in the toxic effects caused by A. adenophora
Materials and methods
General comment, for the sake of the reader who isn't an immunologist please try to limit your use of abbreviations or at least define them. Maybe a sentence or two about what a technique does. 
Results
The authors should consider combining the results and discussion section to guide the reader through the data. This would allow for greater detail. For example, how exactly is NRRP3 an immune system damage sensor?
Response: Lines 178-179, "To test the effects of A. adenophora on pyroptosis pathway in vivo, we measured the protein levels of pyroptosis-related factors." was added in the result section. And we have detailed information in lines 218-223: "Inflammasomes are assembled by sensing a variety of tissue injury signals. Diverse stimuli could promote the release of inflammatory cytokines, including IL-1β. NLRP3 is currently the best characterized one, which plays an important role in the immune system as damage sensor. In addition, NLRP3 can also sense and be activated by ROS produced in the cell. It is known that GSDMD is a key pyrotosis executor [48] .
GSDMD can be cleaved into GSDMD-N and GADMD-C by caspase-1. GSDMD-N promotes cell lysis and IL-1β release through forming pores by binding to cell membrane. Inflammasomes are assembled by sensing a variety of tissue injury signals. Diverse stimuli could promote the release of inflammatory cytokines, including IL-1β. NLRP3 is currently the best characterized one, which plays an important role in the immune system as damage sensor. In addition, NLRP3 can also sense and be activated by ROS produced in the cell. It is known that GSDMD is a key pyrotosis executor [48] . GSDMD can be cleaved into GSDMD-N and GADMD-C by caspase-1. GSDMD-N promotes cell lysis and IL-1β release through forming pores by binding to cell membrane."
The authors mention dose-dependency, a chemical characterization of the plant material and specific concentrations of plant compounds would provide greater support to this statement.
Response:
A. adenophora was ground to uniform power and then homogenized with feed to produce different levels of diet. The results showed that the degree of oxidative stress and pyroptosis aggravated with the increased levels of A. adenophora-administration. Plant material chemical characterization was not performed in this study, but could be found in our previous studies related to study on the biological properties of active compounds from Ageratina adenophora (Title: Euptox A induces G1 arrest and autophagy via p38 MAPK-and PI3K/Akt/mTOR-mediated pathways in mouse splenocytes).
Discussion
The authors set out to investigate if A. adenophora causes oxidative stress and pyroptosis. A figure illustrating the pyroptosic pathway and a point by point discussion of this pathway with regard to the experimental results would improve the discussion.
Response: A schematic diagram of A. adenophora causes oxidative stress and pyroptosis ( Figure   8 ) was added in this revised version manuscript. It will be helpful for understanding pyroptosic pathway. And we have revised the discussion section in lines 218-223: "Inflammasomes are assembled by sensing a variety of tissue injury signals. Diverse stimuli could promote the release of inflammatory cytokines, including IL-1β. NLRP3 is currently the best characterized one, which plays an important role in the immune system as damage sensor. In addition, NLRP3 can also sense and be activated by ROS produced in the cell. It is known that GSDMD is a key pyrotosis executor [48] . GSDMD can be cleaved into GSDMD-N and GADMD-C by caspase-1. GSDMD-N promotes cell lysis and IL-1β release through forming pores by binding to cell membrane.
Inflammasomes are assembled by sensing a variety of tissue injury signals. Diverse stimuli could promote the release of inflammatory cytokines, including IL-1β. NLRP3 is currently the best characterized one, which plays an important role in the immune system as damage sensor. In addition, NLRP3 can also sense and be activated by ROS produced in the cell. It is known that
